| 영문 | dengue fever | 한글 | 뎅기 |
|---|---|---|---|
| 설명 | 주로 열대지방에서 발생하는 바이러스성 열병. 4~8일의 잠복기를 거쳐 급격하게 발열하고, 결막충혈-관절통-근육통-백혈구감소 등의 증상을 보인다. 대부분 7~10일 후에는 회복되며, 사망하는 예는 드물다. 미국의 세균학자인 C.F. 크레이그는 1907년 필리핀에서 뎅기열은 모기에 의해 감염된다는 것을 확인-보고했다. 제2차 세계대전 직후 미국의 세균학자 A. B. 세이빈은 그의 연구에 의해 뎅기열 바이러스에는 면역학적으로 네가지 형이 있다고 밝혔다. 뎅기열 바이러스를 매개하는 모기에는 이집트숲모기(Aedes aegypti)와 흰줄숲모기(Aedes albopictus)가 알려져 있다. 이 병에 걸리고 나면 면역이 생기지만 지속기간은 비교적 짧다. |
||
| DHF/DSS | dengue hemorrhagic fever/ dengue shock syndrome |
|---|---|
| DHF | Dengue Hemorrhagic Fever |
| DSS | 1) Double Simultaneous Stimulation 2) Dengue Shock Syndrome |
| DEN | denervation; dengue; dermatitis exfoliativa neonatorum; Device Experience Network [of the CDRH]; die... |
| DHF | dengue hemorrhagic fever; dihydrofolate; dorsihyperflexion |
| DHF/DSS | Dengue Haemorrhagic Fever/Dengue Shock Syndrome |
|---|---|
| DEN | Dengue |
| DEN 2 | Dengue 2 |
| DF | Dengue Fever |
| DHF | Dengue Haemorrhagic Fever |
| dengue | Tropical disease caused by a flavivirus (one of the arboviruses), transmitted by mosquitoes. A more serious complication is dengue shock syndrome, a haemorrhagic fever probably caused by an immune complex hypersensitivity after re exposure. (18 Nov 1997) |
|---|---|
| dengue fever | <microbiology> A tropical disease caused by dengue virus (Arbovirus), that is transmitted by the bite of an infected mosquito of the genus Aedes). Four severity grades of the illness are seen: grade I (fever and constitutional symptoms), grade II (grade I plus spontaneous bleeding of skin, gums or gastrointestinal tract), grade III (grade II plus agitation and circulatory failure) and grade IV (profound shock). Grade I infection is seen most frequently in world travelers, where it is usually self-limited and rarely fatal. The other grades are referred to as dengue haemorrhagic fever and are often fatal. Dengue haemorrhagic fever appears to be an infection by one of the other dengue viruses. Prior immunity to a different dengue virus type appears to be important in the development of the more serious haemorrhagic form. Vaccines are available. Protection from mosquitoes is an important preventive measure. (27 Sep 1997) |
| dengue haemorrhagic fever | <microbiology> A tropical disease caused by dengue virus (Arbovirus), that is transmitted by the bite of an infected mosquito of the genus Aedes). Four severity grades of the illness are seen: grade I (fever and constitutional symptoms), grade II (grade I plus spontaneous bleeding of skin, gums or gastrointestinal tract), grade III (grade II plus agitation and circulatory failure) and grade IV (profound shock). Grade I infection is seen most frequently in world travelers, where it is usually self-limited and rarely fatal. The other grades are referred to as dengue haemorrhagic fever and are often fatal. Dengue haemorrhagic fever appears to be an infection by one of the other dengue viruses. Prior immunity to a different dengue virus type appears to be important in the development of the more serious haemorrhagic form. Vaccines are available. Protection from mosquitoes is an important preventive measure. (27 Sep 1997) |
| dengue shock syndrome | <syndrome> Dengue fever of grade III or IV severity. (05 Mar 2000) |
| dengue virus | A species of the genus flavivirus which causes an acute febrile and sometimes haemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known. (12 Dec 1998) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |
| vaccines, inactivated | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. (12 Dec 1998) |
| vaccines, synthetic | Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. (12 Dec 1998) |
Synonyms : Vaccines, Dengue
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|